# Celldex Therapeutics, Inc.: Form 8-K, filed May 7, 2026

- Company: [Celldex Therapeutics, Inc.](/companies/cldx.md) (CIK 744218)
- Form: 8-K
- Filed: 2026-05-07
- Accepted by EDGAR: May 7, 2026, 16:01 ET
- Period: 2026-05-07
- Accession: 0001171843-26-003153
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/744218/000117184326003153/f8k_050726.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/744218/000117184326003153/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/744218/000117184326003153/f8k_050726.htm

Filed May 7, 2026.
Source: SEC EDGAR, the filing index for accession 0001171843-26-003153. Last ingested by Listed: Nov 5, 2026, 19:04 ET. No prices; not investment advice.